Are closed-loop systems for intensive insulin therapy ready for prime time in the ICU?

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 17, Issue 2, 2014, Pages 190-199

  Okabayashi, Takehiro ^a   Shima, Yasuo ^a  

^a Kochi Health Sciences Center   (Japan)

Author keywords

Closed loop; Critically ill; Hyperglycemia; Hypoglycemia; Intensive insulin therapy; Surgery; Tight glycemic control

Indexed keywords

BLOOD GLUCOSE; CRITICAL ILLNESS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE; INTENSIVE CARE UNITS; POSTOPERATIVE CARE;

EID: 84894086721     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000026     Document Type: Review

References (38)

1. Finfer S, Liu B, Chittock DR, et al., NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012; 367:1108-1118.
2. Agus MS, Steil GM, Wypij D, et al., SPECS Study Investigators. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 2012; 367:1208-1219.
3. Kavanagh BP, McCowen KC. Glycemic control in the ICU. N Engl J Med 2010; 363:2540-2546.
4. Finfer S, Chittock DR, Su SY, et al., NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283-1297.
5. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359-1367.
6. Patel A, MacMahon S, Chalmers J, et al., ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572.
7. Duckworth W, Abraira C, Moritz T, et al., VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009; 360:129-139.
8. Brunkhorst FM, Engel C, Bloos F, et al., German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139.
9. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multicentre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009; 35:1738-1748.
10. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180:821-827.
11. Kansagara D, Fu R, Freeman M, et al. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 2011; 154:268-282.
12. Dellinger RP, Levy MM, Rhodes A, et al., Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013; 39:165-228.
13. Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol 2011; 10:931-941.
14. Vincent AM, Callaghan BC,Smith AL, Feldman EL. Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 2011; 7:573-583.
15. Sarazawa K, Nakano A, Uzui H, et al. Acute hyperglycemia causes microvascular damage, leading to poor functional recovery and remodeling in patients with reperfused ST-segment elevation myocardial infarction. J Nucl Cardiol 2012; 19:507-514.
16. Lapar DJ, Hajzus VA, Zhao Y, et al. Acute hyperglycemic exacerbation of lung ischemia-reperfusion injury is mediated by receptor for advanced glycation end-products signaling. Am J Respir Cell Mol Biol 2012; 46:299-305.
17. Vanhorebeek I, Gunst J, Derde S, et al. Insufficient activation of autophagy allows cellular damage to accumulate in critically ill patients. J Clin Endocrinol Metab 2011; 96:E633-E645.
18. Ryter SW, Cloonan SM, Choi AM. Autophagy: a critical regulator of cellular metabolism and homeostasis. Mol Cells 2013; 36:7-16
19. Vanhorebeek I, Gunst J, Derde S, et al. Mitochondrial fusion, fission, and biogenesis in prolonged critically ill patients. J Clin Endocrinol Metab 2012; 97:E59-E64.
20. Kim HJ, Kim SH, Yun JM. Fisetin inhibits hyperglycemia-induced proinflammatory cytokine production by epigenetic mechanisms. Evid Based Complement Altern Med 2012; 2012:639469.
21. Masters SL, Latz E, O'Neill LA. The inflammasome in atherosclerosis and type 2 diabetes. Sci Transl Med 2011; 3:81ps17.
22. Sheng L, Zhou Y, Chen Z, et al. NF-kB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action. Nat Med 2012; 18:943-949.
23. Pettersson US, Christoffersson G, Massena S, et al. Increased recruitment but impaired function of leukocytes during inflammation in mouse models of type 1 and type 2 diabetes. PLoS One 2011; 6:e22480.
24. Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab 2011; 14:575-585.
25. Parathath S, Grauer L, Huang LS, et al. Diabetes adversely affects macrophages during atherosclerotic plaque regression in mice. Diabetes 2011; 60:1759-1769.
26. Choi SW, Benzie IF, Ma SW, et al. Acute hyperglycemia and oxidative stress: direct cause and effect? Free Radic Biol Med 2008; 44:1217-1231.
27. Shao B, Bayraktutan U. Hyperglycaemia promotes cerebral barrier dysfunction through activation of protein kinase C-b. Diabetes Obes Metab 2013; 15:993-999.
28. Cribbs SK, Martin GS, Rojas M. Monitoring of endothelial dysfunction in critically ill patients: the role of endothelial progenitor cells. Curr Opin Crit Care 2008; 14:354-360.
29. Atkinson BJ, Griesel BA, King CD, et al. Moderate GLUT4 overexpression improves insulin sensitivity and fasting triglyceridemia in high-fat diet-fed transgenic mice. Diabetes 2013; 62:2249-2258.
30. Pound LD, Oeser JK, O'Brien TP, et al. G6PC2: a negative regulator of basal glucose-stimulated insulin secretion. Diabetes 2013; 62:1547-1556.
31. Hanazaki K, Maeda H, Okabayashi T. Tight perioperative glycemic control using an artificial endocrine pancreas. Surg Today 2010; 40:1-7.
32. Falciglia M, Freyberg RW, Almenoff PL, et al. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009; 37:3001-3009.
33. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461.
34. Wilson M, Weinreb J, Hoo GW. Intensive insulin therapy in critical care: a review of 12 protocols. Diabetes Care 2007; 30:1005-1011.
35. Okabayashi T, Kozuki A, Sumiyoshi T, Shima Y. Technical challenges and clinical outcomes of using a closed-loop glycemic control system in the hospital. J Diabetes Sci Technol 2013; 7:238-246.
36. Okabayashi T, Nishimori I, Maeda H, et al. Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial. Diabetes Care 2009; 32:1425-1427.
37. Yamashita K, Okabayashi T, Yokoyama T, et al. The accuracy of a continuous blood glucose monitor during surgery. Anesth Analg 2008; 106:160-163.
38. Yamashita K, Okabayashi T, Yokoyama T, et al. Accuracy and reliability of continuous blood glucose monitor in postsurgical patients. Acta Anaesthesiol Scand 2009; 53:66-71.